Cost-Effectiveness of Routine Screening for Critical Congenital Heart Disease in US Newborns

Abstract

This study provides the first US cost-effectiveness analysis of CCHD screening in the United States could be reasonably cost-effective. We anticipate data from states that have recently approved or initiated CCHD screening will become available over the next few years to refine these projections.